Patrick J. Langlois
Director/Board Member at NEWRON PHARMACEUTICALS S.P.A.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Luca Benatti | M | 63 | 26 years | |
Stefan Weber | M | 60 | 12 years | |
Gaël Champier | M | - |
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The private company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | - |
Claire de Saint Blanquat | F | 51 | 4 years | |
Filippo Moriggia | M | - | 8 years | |
Henry Wheeler | M | 40 | 3 years | |
Jean-Yves Blay | M | 61 | 7 years | |
Nawal Ouzren | F | 45 | 7 years | |
Roberto Galli | M | - | 22 years | |
Véronique Chabernaud | M | 62 | 9 years | |
John Furey | M | 59 | 5 years | |
Eric Forquenot de la Fortelle | M | - | 9 years | |
Pascale Boissel | F | 57 | 4 years | |
Ulrich Köstlin | M | 71 | 11 years | |
Jean Nicolas Trebouta | M | 60 | 13 years | |
Armelle Cuvillier | M | - |
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The private company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | - |
Bertrand Louvet | M | 86 |
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The private company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | - |
Dennis Dionne | M | - | 9 years | |
Ravi Anand | M | 67 | 19 years | |
Nicola Beltraminelli | M | 54 | 2 years | |
Valerie Salentey | M | - | 4 years | |
Frederic Lombard | M | 49 | 3 years | |
Patrick Jourdan-Laforte | M | - |
PJL Consulting
PJL Consulting Miscellaneous Commercial ServicesCommercial Services PJL Consulting provides business and management consulting services. | - |
Géraldine Honnet | M | - | 4 years | |
Odile Laurent | F | 63 | 7 years | |
Sally Bennett | M | 52 | 2 years | |
Audrey Legentil-Duméry | F | - | 9 years | |
Laura Faravelli | F | - | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Dominique Costantini | M | 69 | 14 years | |
Graham Hetherington | M | 65 | 6 years | |
Marco Caremi | M | 67 | 21 years | |
Laurent Nguyen-Cong-Duc | M | - | - | |
Bo Jesper Hansen | M | 66 | 5 years | |
Michel de Rosen | M | 73 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 6 years |
Danièle Guyot-Caparros | F | 64 | 9 years | |
Albert Saporta | M | 73 | 15 years | |
Pierre F. Dodion | M | 69 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | 12 years |
Michel Arié | M | 77 | 4 years | |
Robert Leslie Holland | M | 69 | 8 years | |
Roberto Gradnik | M | 68 | 3 years | |
Anne Minto | F | 70 | 8 years | |
David R. Ginsburg | M | 71 | 8 years | |
Michael Rosenblatt | M | 76 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 1 years |
Per Anders Göte Samuelsson | M | 63 | - | |
François Romagné | M | 60 | 14 years | |
William Burns | M | 76 | 8 years | |
David Solomon | M | 63 | - | |
Laure-Hélène Mercier | F | 46 | 14 years | |
Louis Champion | M | 64 | 11 years | |
Jean-Michel Levy | M | 75 | 3 years | |
Kathleen Anne Nealon | F | 70 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 4 years |
Christian Chavy | M | 75 | 2 years | |
Robert Zeldin | M | 61 | 4 years | |
André Ulmann | M | - | 2 years | |
Lawrence Rosen | M | 66 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | 16 years |
Catherine Dunand | F | 62 | 3 years | |
Charles Ruban | M | 52 | 9 years | |
Robert Cawthorn | M | 88 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 14 years |
Thomas Hofstaetter | M | 75 | 9 years | |
Jeffrey Leiden | M | 68 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 6 years |
Jean-Luc Bélingard | M | 74 | 4 years | |
Philippe Pouletty | M | 65 | 15 years | |
Marcel Rozencweig | M | 78 | 8 years | |
David Stout | M | 69 | 6 years | |
Russell Greig | M | 71 | 4 years | |
Barry James Price | M | 80 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 14 years |
Delphine Lucas | M | - | 7 years | |
Igor Landau | M | 78 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | 5 years |
Richard Markham | M | 73 |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | 2 years |
Ludovic Robin | M | - | 8 years | |
Joseph Zakrzewski | M | 60 | 4 years | |
Tatjana Anni Hilde May | F | 58 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | 7 years |
Ekaterina Smirnyagina | M | 58 | - | |
Joseph deBethizy | M | 74 | 9 years | |
Maria Gabriella Camboni | M | 66 | - | |
Frédérique Brune | M | 58 | - | |
Brooke Clarke | F | - | 5 years | |
Joyson Karakunnel | M | 54 | 3 years | |
Tracy Rossin | F | 46 | 3 years | |
Raymond Pratt | M | 73 | 7 years | |
Karsten Munk Knudsen | M | 53 | - | |
Danielle Spangler | F | - | - | |
Roger Adsett | M | 55 | 11 years | |
Martin Savitzky | M | - |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 9 years |
Fred Banti | M | 67 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 5 years |
Lars Fruergaard Jorgensen | M | 58 | 6 years | |
Elisabeth V. Carstensen | M | 55 | - | |
Anne-Sophie Herelle | F | 43 | - | |
Catherine Moukheibir | F | 64 | 5 years | |
Hiroyuki Kojima | M | - |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 6 years |
Per Gunnar Falk | M | - | - | |
Jeffrey M. Dener | M | - |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 3 years |
Deanna M. Petersen | F | 62 | 6 years | |
Patrick Lee | M | 67 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 10 years |
Frank Morich | M | 69 | 6 years | |
David Mazzo | M | 67 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 6 years |
Brian Schwab | M | 59 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 2 years |
Thomas B. Okarma | M | 78 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 1 years |
Anita B. Bessler | F | 76 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | 2 years |
Jennifer Butler | F | - | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 63 | 63.00% |
Ireland | 14 | 14.00% |
Italy | 12 | 12.00% |
United States | 11 | 11.00% |
United Kingdom | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Patrick J. Langlois
- Personal Network